CHINA BIOLOGIC PRODS HLDGS I's ticker is CBPO and the CUSIP is G21515104. A total of 76 filers reported holding CHINA BIOLOGIC PRODS HLDGS I in Q2 2019. The put-call ratio across all filers is 1.01 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $350,739,000 | +0.3% | 2,962,076 | 0.0% | 3.47% | +24.6% |
| Q4 2020 | $349,851,000 | +6.3% | 2,962,076 | 0.0% | 2.78% | +11.5% |
| Q3 2020 | $329,205,000 | +8.8% | 2,962,076 | 0.0% | 2.49% | -9.9% |
| Q2 2020 | $302,665,000 | +1.9% | 2,962,076 | +7.7% | 2.77% | -30.9% |
| Q1 2020 | $296,937,000 | -7.3% | 2,751,200 | 0.0% | 4.00% | +0.3% |
| Q4 2019 | $320,185,000 | +1.7% | 2,751,200 | 0.0% | 3.99% | -7.9% |
| Q3 2019 | $314,930,000 | +20.1% | 2,751,200 | 0.0% | 4.33% | -26.2% |
| Q2 2019 | $262,189,000 | +4.4% | 2,751,200 | 0.0% | 5.86% | -16.2% |
| Q1 2019 | $251,047,000 | +20.2% | 2,751,200 | 0.0% | 6.99% | -19.3% |
| Q4 2018 | $208,844,000 | – | 2,751,200 | – | 8.66% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kite Lake Capital Management (UK) LLP | 207,382 | $24,135,000 | 76.46% |
| Maso Capital Partners Ltd | 539,597 | $62,798,000 | 20.20% |
| York Capital Management Global Advisors, LLC | 1,102,163 | $128,270,000 | 7.40% |
| HHLR ADVISORS, LTD. | 2,751,200 | $320,185,000 | 3.99% |
| Dalton Investments, Inc. | 15,551 | $1,810,000 | 1.14% |
| Athos Capital Ltd | 8,290 | $965,000 | 0.96% |
| Myriad Asset Management Ltd. | 67,019 | $7,799,000 | 0.94% |
| Temasek Holdings (Private) Ltd | 990,000 | $115,216,000 | 0.75% |
| OXFORD ASSET MANAGEMENT LLP | 211,646 | $24,631,000 | 0.68% |
| AGF Investments America Inc. | 12,230 | $1,423,000 | 0.47% |